.jpg?cb=5814680665433cc71e4f5bd2d8112904&w=1200)
Novo Holdings Acquire Majority Stake in Single Use Support
Novo Holdings will acquire an approximately 60% controlling stake in Single Use Support, alongside the two company founders who will each retain 10% and Danaher which will retain 20% of the share capital. Founded in 2017 in Kufstein, Austria by…
Resolving Image Integrity Challenges in Pharmaceutical Research
Western blots are frequently included in pharmaceutical research papers to report results when analysing proteins in a sample. However, research shows that Western blot images are a common source of integrity issues, the publication of which can be harmful to…
Ajax Therapeutics Raises $95 Million
Ajax Therapeutics, Inc. have announced the closing of an oversubscribed $95 million Series C financing. Proceeds from the financing will be used to support the clinical development of Ajax’s first-in-class Type II JAK2 inhibitor, AJ1‑11095, for the treatment of myelofibrosis, as…
Entia Gets Go-Ahead for World’s First At-Home Blood Monitoring Solution
Entia’s new, home-use, full blood count analyser that provides personalised and preventative care for cancer patients outside of hospital has been approved for use in the UK. The unique analyser is at the heart of Entia’s comprehensive remote patient monitoring service, Liberty. About the size…
ArgusEye Closes €2.8 Million Funding to Accelerate Bioprocessing
ArgusEye have announced the close of its funding, raising €2.8 million EUR (~£2.4 million GBP) bringing the total raised by the Company to €3.45 million EUR (~£3 million GPB). The funding was led by Voima Ventures, a Nordic early-stage investor that…
Sciensus Partners with Observia to Improve Medication Adherence
Ensuring patient adherence to medication is a crucial factor in delivering better health outcomes for patients – but adherence for chronic disease is just 50 per cent globally, leading to significant human and economic hardship. In a bid to tackle…
Frank Jäger Becomes Commercial Director of CCL Clinical
Frank Jäger has been appointed Commercial Director of the newly created CCL Clinical business unit. “The fact that the world’s largest label manufacturer, CCL Label, is setting up a business unit dedicated to the research-based pharmaceutical industry is a definite…
Novo Nordisk and Metaphore Biotechnologies Announce Obesity Research Collaboration
Metaphore Biotechnologies have joined Flagship Pioneering in announcing a research collaboration with Novo Nordisk to develop up to two next-generation therapeutics for obesity management. Under the terms of the agreement, Novo Nordisk may pay up to $600 million in upfront,…
Ennogen Receive £30 Million Credit Facility for Growth
Santander UK has provided Ennogen Healthcare International, a growing UK based pharmaceuticals manufacturer, with a £30 million loan facility to support its international expansion plans. Established in 2011, Ennogen is a pharmaceutical and healthcare company focused on three key therapeutic…
Ribobay Pharma Boosts Offering with Cytiva’s FlexFactory Platform
Ribobay Pharma, a leading Chinese biopharmaceutical CRDMO and a spin-off company of General Biol (Anhui) Co., Ltd, will provide cGMP-level oligonucleotide (oligo) CRDMO services to the world using Cytiva’s first FlexFactory platform for oligo manufacturing. It is scheduled to commence manufacturing in…